SCHEMBL30579441

SCHEMBL30579441

O=C(O)c1ccc2c(O)ccc(O)c2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.64
CA1 P00915 4/20 0.64
CA2 P00918 4/20 0.64
CA6 P23280 4/20 0.64
CA9 Q16790 4/20 0.64
KDM4E B2RXH2 4/20 0.64
CA4 P22748 3/20 0.64
CA7 P43166 3/20 0.64
CA14 Q9ULX7 3/20 0.64
MAPT P10636 2/20 0.64
POLB P06746 1/20 0.64
GAA P10253 1/20 0.64
PTGS2 P35354 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.64
LCK P06239 1/20 0.55
HTT P42858 1/20 0.52
KDM5A P29375 2/20 0.48
TSHR P16473 2/20 0.48
TP53 P04637 2/20 0.48
CDC25B P30305 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3389495 1.00 CA12 (0.64) CA12CA1CA2CA6CA9
SCHEMBL16494696 0.86 KDM4E (0.53) CA12CA1CA2CA6CA9
SCHEMBL28020171 0.81 KDM4E (0.57) CA12CA1CA2CA6CA9
SCHEMBL27913796 0.80 CASP6 (0.62) CA12CA1CA2CA6CA9
SCHEMBL31279968 0.80 TSHR (0.58) CA12CA1CA2CA6CA9
SCHEMBL29399562 0.80 TSHR (0.58) CA12CA1CA2CA6CA9
SCHEMBL17254441 0.80 TSHR (0.58) CA12CA1CA2CA6CA9
SCHEMBL9409009 0.79 CA12 (0.54) CA12CA1CA2CA6CA9
Protocatechuic Acid SCHEMBL39435 0.78 CA12 (1.00) CA12CA1CA2CA6CA9
Protocatechuic Acid SCHEMBL30030432 0.78 CA12 (1.00) CA12CA1CA2CA6CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111549045-B Vitamin K improvement by utilizing recombinant bacillus natto 2 Method for producing yield 西宝生物科技(上海)股份有限公司 2023-09-19 CN claimed
CN-113564224-B Biomarkers for malignant transformation of oral submucosa fibrosis 台达电子工业股份有限公司 2025-04-11 CN disclosed
EP-4499878-A2 TAXONOMIC SIGNATURES AND METHODS OF DETERMINING THE SAME Baylor College of Medicine (US) 2025-02-05 EP disclosed
CN-110573150-B Composition for inhibiting proliferation of bacteria having menaquinone synthesis pathway via furalosine or furalosine derivative 内斯托尔株式会社 2024-02-27 CN disclosed
WO-2023192815-A2 TAXONOMIC SIGNATURES AND METHODS OF DETERMINING THE SAME BAYLOR COLLEGE OF MEDICINE (US) 2023-10-05 WO disclosed
CN-111549045-B Vitamin K improvement by utilizing recombinant bacillus natto 2 Method for producing yield 西宝生物科技(上海)股份有限公司 2023-09-19 CN disclosed
CN-111549045-B Vitamin K improvement by utilizing recombinant bacillus natto 2 Method for producing yield 西宝生物科技(上海)股份有限公司 2023-09-19 CN disclosed